Neurofunctional Outcomes After Pediatric SARS-CoV-2 Infection and Acute Interferon-Related Gene Expression: An Exploratory Observational Pilot Study
Authors:
- Alice dos Santos Nunes FerreiraAFAlice dos Santos Nunes Ferreira
- Bethania Alves Avelar-FreitasBABethania Alves Avelar-Freitas
- Marco Antônio Alves SchetinoMSMarco Antônio Alves Schetino
- Iara Cristine Jardim LoyolaILIara Cristine Jardim Loyola
- Viviane Pires de SousaVSViviane Pires de Sousa
- Rosalina Tossige-GomesRTRosalina Tossige-Gomes
- Tamiris Campos DuarteTDTamiris Campos Duarte
- Jonathan Moreira LopesJLJonathan Moreira Lopes
- Juliane Duarte SantosJSJuliane Duarte Santos
- Mariana Aguiar MatosMMMariana Aguiar Matos
- Danilo Bretas de OliveiraDODanilo Bretas de Oliveira
- Etel Rocha-VieiraEREtel Rocha-Vieira
Open Access
Abstract
Long-term neurofunctional outcomes after pediatric SARS-CoV-2 infection remain incompletely understood, particularly in relation to acute antiviral immune responses. This exploratory observational pilot study assessed neurofunctional performance approximately six months after infection and its association with acute nasopharyngeal interferon-related gene expression. Sixteen children aged 3–10 years with RT-qPCR-confirmed mild COVID-19 underwent cognitive, gross motor, and functional exercise assessments. Transcript abundance of IFNA2, IFNB1, IFNL2/3, IFI6, and OAS2 was evaluated by qPCR. Five children (31.25%) scored below the age-specific MMSE cutoff, and five of 14 children (35.71%) had below-average TGMD-2 performance. Thirteen completed the ISWT, achieving 53.95 ± 13.55% of the individually predicted distance. IFNB1, IFI6, and OAS2 were detected in all acute-phase samples, whereas IFNA2 and IFNL2/3 were not detected. No statistically significant associations were identified between the detected transcripts and subsequent neurofunctional outcomes. Although the small sample size, absence of pre-infection assessments, and lack of an uninfected comparison group limit interpretation of the findings, this pilot study provides preliminary descriptive data integrating acute mucosal interferon-related gene expression with subsequent neurofunctional assessments in children, supporting further investigation in larger, controlled cohorts.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (001)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-04955-23)
- Secretaria de Estado de Saúde de Minas Gerais (007/2022)
This publication has 34 references indexed in Scilit:
- Trends in physical fitness among children and adolescents in Europe: A systematic review and meta-analyses during and after the COVID-19 pandemicJournal of Sport and Health Science, 2025
- Coronavirus disease 2019 (COVID-19) in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post–COVID-19 conditions, prevention strategies, and future directionsJournal of Allergy and Clinical Immunology, 2024
- Characterizing Long COVID in Children and AdolescentsJAMA, 2024
- Long COVID: a clinical updateThe Lancet, 2024
- Global Changes in Child and Adolescent Physical Activity During the COVID-19 PandemicJAMA Pediatrics, 2022
- Multiple early factors anticipate post-acute COVID-19 sequelaeCell, 2022
- Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2Nature Communications, 2021
- Activation and evasion of type I interferon responses by SARS-CoV-2Nature Communications, 2020
- Impairment in planning tasks of children and adolescents with anxiety disordersPsychiatry Research, 2019
- Reference Equation for the Incremental Shuttle Walk Test in Children and AdolescentsThe Journal of Pediatrics, 2015